New injection aims to starve prostate cancer
NCT ID NCT07457164
Summary
This study is testing a new injection called Teverelix DP for men with advanced prostate cancer that has spread or cannot be cured. The drug works by quickly lowering testosterone, a hormone that fuels prostate cancer growth. Researchers will give 40 men a series of injections over several months to see if the treatment safely and effectively keeps testosterone at very low levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.